Literature DB >> 21603981

Gene polymorphisms involved in folate and methionine metabolism and increased risk of sporadic colorectal adenocarcinoma.

José Luiz Miranda Guimarães1, Maria de Lurdes Ayrizono, Cláudio Saddy Rodrigues Coy, Carmen Silvia Passos Lima.   

Abstract

This pilot study has compared the polymorphic genotype frequencies of methylenetetrahydrofolate reductase (MTHFR A1298C and C677T), methionine synthase (MTR A2756G), methionine synthase reductase (MTRR A66G), and thymidylate synthase (TS 2R/3R) in 113 patients with sporadic colorectal adenocarcinoma (SCA) and 188 healthy blood donors, used as matched controls. The aim was to assess the role of these genotypes in the increased risk of SCA among the southeastern Brazilian population. Carriers of genotype MTRR 66GG, or the combined variants MTHFR 1298AC + CC plus 677CT + TT, or MTHFR 677CT + TT plus MTR 2756AG + GG, or MTHFR 1298AC + CC plus 677CT + TT plus MTR 2756AG + GG, or yet, MTHFR 1298AC + CC plus 677CT + TT plus MTRR 66AG + GG, respectively, showed an increased risk of the order of 1.99-, 3.26-, 2.22-, 10.92-, and 14.88-fold of developing SCA when compared with carriers of the other studied polymorphic genotypes, whether in isolation or in combination. In addition, individuals with the MTHFR 677CT + TT or the MTR 2756AG + GG genotypes had a 2.12- and a 1.42-fold increased risks of SCA onset before 50 years of age. African-Brazilians with the MTRR 66GG genotype had a 1.98-fold increased risk of SCA while individuals with the MTR 2756AG + GG and the MTHFR 677CT + TT genotypes showed a 2.11- and a 1.62-fold increased risk of undifferentiated and advanced tumors at diagnosis, respectively. Carriers of genotype MTHFR 1298AC + CC or MTHFR 1298AC + CC plus MTRR 66AG + GG had a 1.42- and a 3.07-fold increased risk of rectal tumor, respectively. Additionally, carriers of MTHFR 677CT + TT or MTHFR 677CT + TT plus TS 2R/3R + 3R/3R had a 1.55- and a 5.39-fold increased risk for colon tumor, respectively, in comparison with carriers of the wild genotypes. These data suggest that all polymorphisms coding for folate and methionine-dependent enzymes, particularly when present in combination with other polymorphisms, have consistent roles in the increased risk of SCA among the southeastern population of Brazil.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21603981     DOI: 10.1007/s13277-011-0185-2

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  43 in total

1.  The ancestry of Brazilian mtDNA lineages.

Authors:  J Alves-Silva; M da Silva Santos; P E Guimarães; A C Ferreira; H J Bandelt; S D Pena; V F Prado
Journal:  Am J Hum Genet       Date:  2000-06-28       Impact factor: 11.025

2.  Polymorphisms in the thymidylate synthase and serine hydroxymethyltransferase genes and risk of adult acute lymphocytic leukemia.

Authors:  Christine F Skibola; Martyn T Smith; Alan Hubbard; Barry Shane; Abby C Roberts; Graham R Law; Sara Rollinson; Eve Roman; Raymond A Cartwright; Gareth J Morgan
Journal:  Blood       Date:  2002-05-15       Impact factor: 22.113

3.  A second common mutation in the methylenetetrahydrofolate reductase gene: an additional risk factor for neural-tube defects?

Authors:  N M van der Put; F Gabreëls; E M Stevens; J A Smeitink; F J Trijbels; T K Eskes; L P van den Heuvel; H J Blom
Journal:  Am J Hum Genet       Date:  1998-05       Impact factor: 11.025

4.  Exon-specific DNA hypomethylation of the p53 gene of rat colon induced by dimethylhydrazine. Modulation by dietary folate.

Authors:  Y I Kim; I P Pogribny; R N Salomon; S W Choi; D E Smith; S J James; J B Mason
Journal:  Am J Pathol       Date:  1996-10       Impact factor: 4.307

5.  Folate deficiency causes uracil misincorporation into human DNA and chromosome breakage: implications for cancer and neuronal damage.

Authors:  B C Blount; M M Mack; C M Wehr; J T MacGregor; R A Hiatt; G Wang; S N Wickramasinghe; R B Everson; B N Ames
Journal:  Proc Natl Acad Sci U S A       Date:  1997-04-01       Impact factor: 11.205

6.  CpG island methylator phenotype in colorectal cancer.

Authors:  M Toyota; N Ahuja; M Ohe-Toyota; J G Herman; S B Baylin; J P Issa
Journal:  Proc Natl Acad Sci U S A       Date:  1999-07-20       Impact factor: 11.205

7.  Methylenetetrahydrofolate reductase 677 C-->T polymorphism and risk of proximal colon cancer in north Italy.

Authors:  Giuseppe Toffoli; Roberta Gafà; Antonio Russo; Giovanni Lanza; Riccardo Dolcetti; Franca Sartor; Massimo Libra; Alessandra Viel; Mauro Boiocchi
Journal:  Clin Cancer Res       Date:  2003-02       Impact factor: 12.531

Review 8.  Polymorphisms in genes involved in folate metabolism and colorectal neoplasia: a HuGE review.

Authors:  Linda Sharp; Julian Little
Journal:  Am J Epidemiol       Date:  2004-03-01       Impact factor: 4.897

9.  Heterozygote deficiency in thymidylate synthase enhancer region polymorphism genotype distribution in Hungarian colorectal cancer patients.

Authors:  Vilmos Adleff; Erika Hitre; István Köves; Zsolt Orosz; Anna Hajnal; Judit Kralovánszky
Journal:  Int J Cancer       Date:  2004-03-01       Impact factor: 7.396

10.  Genetic polymorphisms in one-carbon metabolism: associations with CpG island methylator phenotype (CIMP) in colon cancer and the modifying effects of diet.

Authors:  Karen Curtin; Martha L Slattery; Cornelia M Ulrich; Jeannette Bigler; Theodore R Levin; Roger K Wolff; Hans Albertsen; John D Potter; Wade S Samowitz
Journal:  Carcinogenesis       Date:  2007-04-21       Impact factor: 4.944

View more
  11 in total

1.  Association of methylenetetrahydrofolate reductase C677T and A1298C polymorphisms with colorectal cancer risk: A meta-analysis.

Authors:  Mengmeng Zhao; Xuelian Li; Chengzhong Xing; Baosen Zhou
Journal:  Biomed Rep       Date:  2013-07-15

2.  The polymorphisms in methylenetetrahydrofolate reductase, methionine synthase, methionine synthase reductase, and the risk of colorectal cancer.

Authors:  Daijun Zhou; Qiang Mei; Han Luo; Bo Tang; Peiwu Yu
Journal:  Int J Biol Sci       Date:  2012-06-08       Impact factor: 6.580

3.  The 677C>T (rs1801133) polymorphism in the MTHFR gene contributes to colorectal cancer risk: a meta-analysis based on 71 research studies.

Authors:  Zan Teng; Lei Wang; Shuang Cai; Ping Yu; Jin Wang; Jing Gong; Yunpeng Liu
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

4.  Methylenetetrahydrofolate reductase C677T polymorphism and colorectal cancer susceptibility: a meta-analysis.

Authors:  Lingyan Xu; Zhiqiang Qin; Feng Wang; Shuhui Si; Lele Li; Peinan Lin; Xiao Han; Xiaomin Cai; Haiwei Yang; Yanhong Gu
Journal:  Biosci Rep       Date:  2017-12-07       Impact factor: 3.840

5.  Association of methylenetetrahydrofolate reductase and methionine synthase polymorphisms with breast cancer risk and interaction with folate, vitamin B6, and vitamin B 12 intakes.

Authors:  Qiao Jiang-Hua; Jiao De-Chuang; Lu Zhen-Duo; Cui Shu-de; Liu Zhenzhen
Journal:  Tumour Biol       Date:  2014-09-13

6.  [Association of methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism and the risk of sporadic colorectal cancer].

Authors:  Imane Baghad; Driss Erreguibi; Rachid Boufettal; Saad Rifki Eljai; Farid Chihab; Sellama Nadifi
Journal:  Pan Afr Med J       Date:  2021-03-18

7.  Methionine synthase A2756G polymorphism and risk of colorectal adenoma and cancer: evidence based on 27 studies.

Authors:  Weixing Ding; Dong-Lei Zhou; Xun Jiang; Lie-Sheng Lu
Journal:  PLoS One       Date:  2013-04-09       Impact factor: 3.240

8.  Lack of association between methionine synthase A2756G polymorphism and digestive system cancer risk: evidence from 3,9327 subjects.

Authors:  Yuan Zhao; Zixian Chen; Yushui Ma; Qing Xia; Feng Zhang; Da Fu; Xiao-Feng Wang
Journal:  PLoS One       Date:  2013-04-16       Impact factor: 3.240

9.  Folate Intake, MTHFR Polymorphisms, and the Risk of Colorectal Cancer: A Systematic Review and Meta-Analysis.

Authors:  Deborah A Kennedy; Seth J Stern; Ilan Matok; Myla E Moretti; Moumita Sarkar; Thomasin Adams-Webber; Gideon Koren
Journal:  J Cancer Epidemiol       Date:  2012-10-18

Review 10.  Associations of the A66G Methionine Synthase Reductase Polymorphism in Colorectal Cancer: A Systematic Review and Meta-Analysis.

Authors:  Noel Pabalan; Eloisa Singian; Lani Tabangay; Hamdi Jarjanazi; Neetu Singh
Journal:  Biomark Cancer       Date:  2015-10-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.